Content about Local anesthetics

March 8, 2013
Benzocaine warning helps Hyland's sales

Last year the Food and Drug Administration warned parents against using the ingredient benzocaine in children to relieve oral pain.

SILVER SPRING, Md. — Last year the Food and Drug Administration warned parents against using the ingredient benzocaine in children to relieve oral pain. Children under the age of 2 years who are teething and given benzocaine should be under the supervision of a doctor, the agency warned.

November 7, 2012
Absorption Pharmaceuticals launches men's intimacy health solution

Absorption Pharmaceuticals recently launched Promescent, an over-the-counter lidocaine-based spray indicated for premature ejaculation.

NEWPORT BEACH, Calif. — Absorption Pharmaceuticals recently launched Promescent, an over-the-counter lidocaine-based spray indicated for premature ejaculation. The product is presently available at www.Promescent.com, through doctors’ offices and independent pharmacies. 

 Created by a urologist, the spray is designed to absorb below the surface of the skin where nerve endings that control ejaculation are located.

August 24, 2012
FDA approves Watson pain patch

The Food and Drug Administration has approved a generic medicated patch for treating pain made by Watson Pharmaceuticals, the company said.

PARSIPPANY, N.J. — The Food and Drug Administration has approved a generic medicated patch for treating pain made by Watson Pharmaceuticals, the company said.

Watson announced the approval of lidocaine topical patch in the 5% strength. The drug is a generic version of Endo Pharmaceuticals' Lidoderm, which had sales of about $1.2 billion during the 12-month period ended in June 2012, according to IMS Health.

June 6, 2012
Ferndale Healthcare launches OTC hemorrhoid therapy

Ferndale Healthcare on Monday announced the launch of RectiCare Anorectal cream, an over-the-counter therapy to help relieve the pain and discomfort associated with hemorrhoids.

FERNDALE, Mich. — Ferndale Healthcare on Monday announced the launch of RectiCare Anorectal cream, an over-the-counter therapy to help relieve the pain and discomfort associated with hemorrhoids. RectiCare is a topical, local anesthetic that contains 5% lidocaine.

Each tube of RectiCare comes with a supply of "finger cots," little cotton covers that fit over the finger. They promote hygienic application, since the finger doesn't come into contact with the product or the area to which it's being applied, the company stated. 

May 31, 2012
FDA warns parents on using benzocaine to relieve pain of teething babies

The Food and Drug Administration on Thursday warned parents against administering benzocaine to their teething babies and advised that parents not use benzocaine at all in children under the age of 2 years unless under the supervision of a family physician.

SILVER SPRING, Md. — The Food and Drug Administration on Thursday warned parents against administering benzocaine to their teething babies and advised that parents not use benzocaine at all in children under the age of 2 years unless under the supervision of a family physician.

April 7, 2011
FDA: Teething OTC drugs associated with risk of methemoglobinemia

The Food and Drug Administration on Thursday posted a notification to healthcare professionals and patients that the agency continues to receive reports of methemoglobinemia, a serious and potentially fatal adverse effect, associated with benzocaine products, which are available as a spray, gel and liquids sold over the counter.

SILVER SPRING, Md. — The Food and Drug Administration on Thursday posted a notification to healthcare professionals and patients that the agency continues to receive reports of methemoglobinemia, a serious and potentially fatal adverse effect, associated with benzocaine products, which are available as a spray, gel and liquids sold over the counter. Benzocaine products are used to relieve pain from a variety of conditions, such as teething, canker sores, and irritation of the mouth and gums.

March 24, 2011
Hi-Tech Pharmacal launches topical pain treatment

The Food and Drug Administration has approved a topical pain treatment made by Hi-Tech Pharmacal, the drug maker said Thursday.

AMITYVILLE, N.Y. — The Food and Drug Administration has approved a topical pain treatment made by Hi-Tech Pharmacal, the drug maker said Thursday.

The agency approved Hi-Tech’s sterile lidocaine jelly in the 2% strength, used for treating pain in procedures involving the urethra, painful urethritis and in endotracheal intubation.

Various versions of the drug had sales of $17 million in 2010, according to IMS Health.

January 18, 2010
Watson files application for Lidoderm generic

Watson Pharmaceuticals has filed for regulatory approval of a generic version of a pain drug...